2017
DOI: 10.1016/j.cgh.2017.05.026
|View full text |Cite
|
Sign up to set email alerts
|

Constructing an Inflammatory Bowel Disease Patient–Centered Medical Home

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
31
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 51 publications
(31 citation statements)
references
References 10 publications
0
31
0
Order By: Relevance
“…Details of the design, implementation, and flow of UPMC Total Care-IBD program have been previously published. 5, 6 The multidisciplinary care team included a social worker, dietitian, schedulers, nurse coordinators, and advanced practice providers, and was led by a gastroenterologist (M.R.) and psychiatrist (E.S.).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Details of the design, implementation, and flow of UPMC Total Care-IBD program have been previously published. 5, 6 The multidisciplinary care team included a social worker, dietitian, schedulers, nurse coordinators, and advanced practice providers, and was led by a gastroenterologist (M.R.) and psychiatrist (E.S.).…”
Section: Methodsmentioning
confidence: 99%
“…5 Initiated in July 2015 with ongoing active enrollment, UPMC Total Care-IBD has assumed care for over 650 patients to date. We aimed to investigate the feasibility, durability, and impact of Total Care-IBD after one year of enrollment and treatment.…”
Section: Introductionmentioning
confidence: 99%
“…Many of the improvements in outcomes we now see are likely to be due to improved communication between patients and members of the IBD multidisciplinary teams through IBD telephone helplines and electronic portals for IBD patients to communicate more openly. Rapid access to out‐patient care will also reduce hospitalisations …”
mentioning
confidence: 99%
“…Rapid access to out-patient care will also reduce hospitalisations. 6 However, the effect of the biological drugs, infliximab and adalimumab, is likely to play an important role in the observations made from Ontario by Rahman et al These drugs have enabled gastroenterologists to focus on new targets such as fistula healing, and to target mucosal healing with more confidence. 7 Over time, the outcomes from using these drugs in the right patients, with the right targets, at the right dose and with the right combinations have incrementally improved.…”
mentioning
confidence: 99%
“…Besides offering close disease activity monitoring, effective implementation of PROMs improves patient engagement in care with downstream benefits in the new value-based models of care. 2,3,14 In conclusion, PROMs increasingly are becoming an integral component of IBD care. The quest for development of an ideal PROM for clinical trials and practice is in full swing, and in the coming decade they will change the way we practice IBD for the better.…”
mentioning
confidence: 99%